Join
Live feed
·
PRReleasevia Quantisnow
LENZ Therapeutics Inc. logo

LENZ Therapeutics Announces Submission of Marketing Authorization Application to European Medicines Agency for VIZZ® for the Treatment of Presbyopia

ByQuantisnow·Wall Street's wire, on your screen.
LENZ· LENZ Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LENZ (LENZ Therapeutics Inc.) and more on Quantisnow.